is tirzepatide compound being discontinued FDA Says Compounded Must Exit the Market COMPOUNDED TIRZEPATIDE ENDS TOMORROW! What

The organization wants to purchase the historic Westlake Theatre and transform it into a community arts and nonprofit hub

ja.ma/42u5OHZ #GLP1 medicines now address weight loss and other health conditions through innovative formulations and expanded indications, highlighting key questions about their efficacy and safety

In this blog post, well explore what glutathione does for us and why its so important

Increased toxicity of a pharmacologically active metabolite of irinotecan (SN38) has been described in patients suffering from Gilberts syndrome as UGT1A1 is the main enzyme responsible for the formation of the inactive SN38 glucuronide (Wasserman et al., 1997)